HPV Vaccination: Prevention of Cervical Cancer in Serbia and in Europe
The identification of the high-risk human papilloma viruses (HPVs) as a cause of cervical cancer offered the possibility for the development of a HPV vaccine. Twenty years after this identification of the HPV types, the first HPV vaccine came to the market. There are three HPV vaccines today on the...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2018-03-01
|
Series: | Acta Facultatis Medicae Naissensis |
Subjects: | |
Online Access: | http://www.degruyter.com/view/j/afmnai.2018.35.issue-1/afmnai-2018-0001/afmnai-2018-0001.xml?format=INT |